
-
BASF exits Xinjiang ventures after Uyghur abuse reports
-
Nordics, Lithuania plan joint purchase of combat vehicles
-
Gold hits record, stocks diverge as Trump fuels Fed fears
-
World could boost growth by reducing trade doubt: IMF chief economist
-
IMF slashes global growth outlook on impact of US tariffs
-
IMF slashes China growth forecasts as trade war deepens
-
Skipper Shanto leads Bangladesh fightback in Zimbabwe Test
-
US VP Vance says 'progress' in India trade talks
-
Ex-England star Youngs to retire from rugby
-
Black Ferns star Woodman-Wickliffe returning for World Cup
-
Kremlin warns against rushing Ukraine talks
-
Mbappe aiming for Copa del Rey final return: Ancelotti
-
US universities issue letter condemning Trump's 'political interference'
-
Pope Francis's unfulfilled wish: declaring PNG's first saint
-
Myanmar rebels prepare to hand key city back to junta, China says
-
Hamas team heads to Cairo for Gaza talks as Israel strikes kill 26
-
Pianist to perform London musical marathon
-
India's Bumrah, Mandhana win top Wisden cricket awards
-
Zurab Tsereteli, whose monumental works won over Russian elites, dies aged 91
-
Roche says will invest $50 bn in US, as tariff war uncertainty swells
-
Pope Francis's funeral set for Saturday, world leaders expected
-
US official asserts Trump's agenda in tariff-hit Southeast Asia
-
World leaders set to attend Francis's funeral as cardinals gather
-
Gold hits record, stocks mixed as Trump fuels Fed fears
-
Roche says will invest $50 bn in US over next five years
-
Fleeing Pakistan, Afghans rebuild from nothing
-
US Supreme Court to hear case against LGBTQ books in schools
-
Pistons snap NBA playoff skid, vintage Leonard leads Clippers
-
Migrants mourn pope who fought for their rights
-
Duplantis kicks off Diamond League amid Johnson-led changing landscape
-
Taliban change tune towards Afghan heritage sites
-
Kosovo's 'hidden Catholics' baptised as Pope Francis mourned
-
Global warming is a security threat and armies must adapt: experts
-
Can Europe's richest family turn Paris into a city of football rivals?
-
Climate campaigners praise a cool pope
-
As world mourns, cardinals prepare pope's funeral
-
US to impose new duties on solar imports from Southeast Asia
-
Draft NZ law seeks 'biological' definition of man, woman
-
Auto Shanghai to showcase electric competition at sector's new frontier
-
Tentative tree planting 'decades overdue' in sweltering Athens
-
Indonesia food plan risks 'world's largest' deforestation
-
Gold hits record, stocks slip as Trump fuels Fed fears
-
Trump helps enflame anti-LGBTQ feeling from Hungary to Romania
-
Woe is the pinata, a casualty of Trump trade war
-
'Like orphans': Argentina mourns loss of papal son
-
Trump tariffs torch chances of meeting with China's Xi
-
X rival Bluesky adds blue checks for trusted accounts
-
China to launch new crewed mission into space this week
-
Morocco volunteers on Sahara clean-up mission
-
Latin America fondly farewells its first pontiff

Medisafe Launches VIA: AI Voice Tech That Supercharges Patient Engagement and Slashes Enrollment Friction
Pharma’s $5B Fix: Always-On Voice That Turns Support Programs into Growth Engines
BOSTON, MA / ACCESS Newswire / April 22, 2025 / Medisafe today launched VIA (Voice Intelligent Agent) - a breakthrough AI voice assistant designed to fix pharma's $5B patient support gap and transform how specialty brands activate, engage, and retain patients.
It's not a bot. It's a breakthrough. VIA represents a new frontier in AI-powered engagement, built for specialty and complex care. If your brand is struggling with program activation or patient reach, it's time to put a voice to the solution.
In conjunction with existing apps, portals and programs, VIA is a fully integrated omnichannel AI solution that reaches patients where they are: through proactive, empathetic voice calls that feel human, not robotic. VIA uses humanized voice outreach to guide patients through onboarding, adherence, and access - while integrating with brand hubs and CRM systems for seamless pharma deployment.
Medisafe VIA is multilingual and supports a range of use cases for healthcare companies - including enrolling in a digital companion program, adherence monitoring, symptom checking, and insurance re-verification - making it a versatile tool for addressing diverse patient needs across regions and care models.
"VIA is the missing link between support programs and the patients who need them," said Rotem Shor, co-founder and CTO of Medisafe. "It is the voice that turns confusion into clarity and how we make patient support human again at scale."
Solving The $5B Black Hole in Patient Support
Pharma spends $5 billion a year on patient support programs - yet only 3% of patients use them. Why? Because most patients don't know they exist or can't navigate the onboarding maze.
VIA flips the script with direct, intelligent outreach.
No extra apps to download.
No extra portals to log into.
Just a humanized voice call - guiding patients, step by step.
And it's not just a voicebot. VIA integrates the full Medisafe experience across voice, SMS, app, and web, which is especially impactful for specialty and rare disease brands where every patient touchpoint matters. VIA has the potential to unlock millions in otherwise lost revenue by bridging the support-to-patient gap.
Why Now? Because the AI Future Is Already Here
Patients already expect seamless, intelligent, and human-centered care - and Medisafe VIA delivers exactly that. It's time to act.
For example, Mayo Clinic reports the use of AI-remote monitoring has resulted in a 40% reduction in readmissions, and Cleveland Clinic is seeing a 94% accuracy rate with its AI-powered virtual triage system.
As digital health redefines the standards of connection and outcomes, organizations that delay risk falling behind. Pharma brands that delay risk losing engagement today, not tomorrow. VIA meets patients where they are, right now - before someone else does.
VIA is designed to plug directly into Medisafe partner brand hubs, CRM systems, and patient support workflows - accelerating implementation without disruption. Specifically, today's release means Medisafe partners can:
Boost enrollment through proactive, guided voice outreach
Improve adherence and reduce no-shows across health systems and provider networks
Deliver timely, frictionless support to patients and caregivers via familiar channels
"VIA represents a critical leap forward in making healthcare engagement more human, accessible, and effective," said Stacey Wasserman, Chief Commercial Officer, Medisafe. "And VIA isn't just patient engagement - it's a revenue unlock for brands struggling to connect support to outcomes,"
Available Now
VIA integrates with Medisafe partners in as little as 30 days and complies with applicable law and regulation - reducing risk while accelerating value. Ready to turn your support program into a growth engine? Meet our team at Asembia 2025 or see more at MedisafeVIA.com .
About Medisafe
Medisafe is the leading medication engagement company that empowers patients to seamlessly manage their treatment journey and holistic health to drive outcomes, while providing real-time intelligence from a database of billions of data points. By combining advanced technology with behavioral science, Medisafe's multiple options support patients, providers, and payers at-scale by supporting better engagement, health management, and outcomes. Over 13M registered patients and caregivers rely on Medisafe's HIPAA and GDPR compliant solution, which is also ISO 27001:2022 and ISO 13845 certified.
Media Contact
[email protected]
Sources
https://www.netguru.com/blog/ai-in-telehealth
https://www.fiercepharma.com/marketing/pharmas-return-5-billion-spent-yearly-patient-support-programs-only-3-use-survey
https://consultqd.clevelandclinic.org/cleveland-clinics-virtual-emergency-medicine-program-treating-the-right-patients-in-the-right-place
SOURCE: Medisafe
View the original press release on ACCESS Newswire
Ch.Kahalev--AMWN